Sign up to save your podcasts
Or
Share FDA Approved Therapy for SOD1 Associated ALS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
FDA Approved Therapy for SOD1 Associated ALS
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
View all episodes
By American Academy of Neurology
4.7
285285 ratings
Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.
Read the related article on the FDA website.
Disclosures can be found at Neurology.org
More shows like Neurology® Podcast
View all
NEJM This Week
321 Listeners
JAMA Clinical Reviews
504 Listeners
Practical Neurology Podcast
53 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
JAMA Neurology Author Interviews
16 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Neurology Today in 5
24 Listeners
Annals On Call Podcast
194 Listeners
The Clinical Problem Solvers
518 Listeners
Neurology Minute
134 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Neurology Exam Prep Podcast
189 Listeners
The Curious Clinicians
375 Listeners
Ninja Nerd
325 Listeners
Continuum Audio
80 Listeners